For example, activation of NF-κB has been strongly linked to intrinsic and acquired resistance to epidermal growth factor receptor (EGFR) inhibitors [181,194,195], while synergistic cytotoxicity has been observed in ABC DLBCL treated with JAK and IKKβ inhibitors [196]. This evidence concerns the gene NFKB1 and diffuse large B-cell lymphoma.